Blood Pressure Classification Status in Children With CKD Following Adoption of the 2017 American Academy of Pediatrics Guideline
Derek K Ng,Megan K Carroll,Susan L Furth,Bradley A Warady,Joseph T Flynn,CKiD Study Investigators,Sahar Fathallah-Shaykh,Anjali Nayak,Martin Turman,Tom Blydt-Hansen,Cynthia Wong,Steve Alexander,Ora Yadin,Elizabeth Ingulli,Robert Mak,Cheryl Sanchez-Kazi,Asha Moudgil,Caroline Gluck,Carolyn Abitbol,Marissa DeFrietas,Chryso Katsoufis,Wacharee Seeherunvong,Larry Greenbaum,Lyndsay Harshman,Craig Langman,H Ann Robert,Sonia Krishnan,Amy Wilson,Stefan Kiessling,Margaret Murphy,Siddharth Shah,Janice Sullivan,Sushil Gupta,Samir El-Dahr,Stacy Drury,Nancy Rodig,Allison Dart,Meredith Atkinson,Arlene Gerson,Tej Matoo,Zubin Modi,Alejandro Quiroga,Bradley Warady,Rebecca Johnson,Vikas Dharnidharka,Stephen Hooper,Susan Massengill,Liliana Gomez-Mendez,Matthew Hand,Joann Carlson,Hanan Tawadrous,Roberto Jodorkovsky,Craig Wong,Frederick Kaskel,Shlomo Shinnar,Jeffrey Saland,Marc Lande,George Schwartz,Anil Mongia,Donna Claes,Mark Mitsnefes,Katherine Dell,Hiren Patel,Pascale Lane,Rulan Parekh,Amira Al-Uzri,Kelsey Richardson,Susan Furth,Larry Copelovitch,Elaine Ku,Joshua Samuels,Poyyapakkam Srivaths,Samhar Al-Akash,Patricia Seo-Mayer,Victoria Norwood,Joseph Flynn,Cynthia Pan,Sharon Bartosh
DOI: https://doi.org/10.1053/j.ajkd.2022.10.009
Abstract:Rationale & objective: Accurate detection of hypertension is crucial for clinical management of pediatric chronic kidney disease (CKD). The 2017 American Academy of Pediatrics (AAP) clinical practice guideline for childhood hypertension included new normative blood pressure (BP) values and revised definitions of BP categories. In this study, we examined the effect of applying the AAP guideline's normative data and definitions to the Chronic Kidney Disease in Children (CKiD) cohort compared with use of normative data and definitions from the 2004 Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Study design: Observational cohort study. Setting & participants: Children and adolescents in the CKiD cohort. Exposure: Clinic BP measurements. Outcome: BP percentiles and hypertension stages calculated using the 2017 AAP guideline and the Fourth Report from 2004. Analytical approach: Agreement analysis compared the estimated percentile and prevalence of high BP based on the 2017 guideline and 2004 report to clinic and combined ambulatory BP readings. Results: The proportion of children classified as having normal clinic BP was similar using the 2017 and 2004 systems, but the use of the 2017 normative data classified more participants as having stages 1-2 hypertension (22% vs 11%), with marginal reproducibility (κ=0.569 [95% CI, 0.538-0.599]). Those identified as having stage 2 hypertension by the 2017 guideline had higher levels of proteinuria compared with those identified using the 2004 report. Comparing use of the 2017 guideline and the 2004 report in terms of ambulatory BP monitoring categories, there were substantially more participants with white coat (3.5% vs 1.5%) and ambulatory (15.5% vs 7.9%) hypertension, but the proportion with masked hypertension was lower (40.2% vs 47.8%, respectively), and the percentage of participants who were normotensive was similar (40.9% vs 42.9%, respectively). Overall, there was good reproducibility (κ=0.799 [95% CI, 0.778-0.819]) of classification by ambulatory BP monitoring. Limitations: Relationship with long-term progression and target organ damage was not assessed. Conclusions: A greater percentage of children with CKD were identified as having hypertension based on both clinic and ambulatory BP when using the 2017 AAP guideline versus the Fourth Report from 2004, and the 2017 guideline better discriminated those with higher levels of proteinuria. The substantial differences in the classification of hypertension when using the 2017 guideline should inform clinical care.